dr. crafton on the impact of parp inhibitors in recurrent ovarian cancer
Published 4 years ago • 120 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
6:20
parp inhibitors in recurrent ovarian cancer
-
1:22
dr. crafton on optimizing treatment selection in recurrent ovarian cancer
-
7:34
parp inhibition’s role in recurrent ovarian cancer
-
3:06
recurrent ovarian cancer: choosing a parp inhibitor
-
1:25
dr. konecny on the indications for parp inhibitors in recurrent ovarian cancer
-
11:05
parp inhibitors in recurrent ovarian cancer
-
1:11
dr. berek discusses the impact of parp inhibitors on ovarian cancer
-
3:44
the future role of parp inhibition in ovarian cancer
-
1:37
dr. konecny on the use of parp inhibitors in patients with ovarian cancer
-
1:32
dr. campos discusses differences between parp inhibitors in recurrent ovarian cancer
-
0:53
dr. mirza on the impact of parp inhibitors in ovarian cancer
-
3:25
ovarian cancer: recurrence after parp inhibition
-
6:50
recurrent ovarian cancer: parp inhibitors compared
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
1:22
dr. gunderson on the use of parp inhibitors in all-comers with ovarian cancer
-
0:48
dr. crane on the impact of parp inhibitors in ovarian cancer
-
2:30
dr. matulonis on toxicities with parp inhibitors in ovarian cancer
-
1:22
dr. penson on the eligibility criteria for parp inhibitors in advanced ovarian cancer